Gadoterate meglumine

钆特酸葡甲胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGadoterate meglumine
Drug Alias NameMeglumini Gadoteras多它灵Meglumine GadoterateGadoterato de megluminaDotarem +[9] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsDiagnostic Self EvaluationHip Fractures +[13] 
Global Approved IndicationsContrast agentsCentral Nervous System Diseases
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryFrance
Original Approved Date1989/01/01
Country/TerritoryBelgiumUnited StatesItaly +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuerbet France
China Registration ClassN/A

Develop Information

Active CompaniesGuerbet FranceThe University Of ChicagoGuerbet Gmbh
Inactive CompaniesAarhus University
Active IndicationsContrast agentsCentral Nervous System DiseasesBreast Neoplasms +[4] 
Inactive IndicationsDiagnostic Self EvaluationHip FracturesPain, Postoperative +[9] 

Other Information

ATC CodeV08CA02
Related LinksWikipediaDrugBankKEGG